Related Experiment Video
Updated: Aug 26, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
The effects of clozapine on the GSK-3-mediated signaling pathway
Ung Gu Kang1, Myoung Suk Seo, Myoung-Sun Roh
1Department of Psychiatry and Behavioral Science, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul 110-799, South Korea.
Abstract:
We investigated the effect of 10 microM clozapine on the activity of glycogen synthase kinase-3beta (GSK-3beta) and its upstream and downstream molecules in SH-SY5Y human neuroblastoma cells. Clozapine activates both Akt- and Dvl-mediated phosphorylation of GSK-3beta through phosphorylation at Ser9, and increased total cellular and intranuclear levels of beta-catenin. Pretreatment with the specific inhibitor of the phosphatidylinositol 3-kinase (PI3K)-Akt pathway, LY294002 (20 microM), prevented the phosphorylation of Akt but did not affect the phosphorylation of GSK-3beta. These results suggest that clozapine regulates the phosphorylation of GSK-3beta through Wnt signal pathways involving Dvl upstream but not through the PI3K-Akt pathway in SH-SY5Y cells.
Insights
Clozapine impacts glycogen synthase kinase-3beta (GSK-3beta) activity in neuroblastoma cells. It activates GSK-3beta via the Dvl-Wnt pathway, not the PI3K-Akt pathway, influencing beta-catenin levels.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Glycogen synthase kinase-3beta (GSK-3beta) is a key regulator in cellular signaling pathways.
- Dysregulation of GSK-3beta is implicated in various neurological disorders.
- Understanding drug effects on GSK-3beta is crucial for therapeutic development.
Purpose of the Study:
- To investigate the effect of clozapine on GSK-3beta activity and associated signaling pathways.
- To determine whether clozapine's effects are mediated through the PI3K-Akt or Wnt pathways.
- To examine clozapine's impact on beta-catenin levels in SH-SY5Y neuroblastoma cells.
Main Methods:
- Utilized SH-SY5Y human neuroblastoma cells.
- Administered clozapine (10 microM) and LY294002 (20 microM, a PI3K-Akt inhibitor).
- Assessed phosphorylation of GSK-3beta (at Ser9), Akt, and levels of beta-catenin.
Main Results:
- Clozapine activated GSK-3beta phosphorylation at Ser9, indicating inactivation.
- This activation was linked to both Akt- and Dvl-mediated pathways.
- Clozapine increased total and intranuclear beta-catenin levels.
- LY294002 inhibited Akt phosphorylation but did not affect GSK-3beta phosphorylation.
Conclusions:
- Clozapine regulates GSK-3beta phosphorylation primarily through Wnt pathway components involving Dvl.
- The PI3K-Akt pathway is not the primary mediator of clozapine's effect on GSK-3beta in these cells.
- Clozapine modulates beta-catenin signaling, suggesting potential roles in neuroprotection or neurodegeneration.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
GPCR Desensitization
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...
